Last update Oct. 11, 2017

كلوروتريانيزان

Limited compatibility

Unsafe. Moderate/severe adverse effects. Compatible under certain circumstances. Follow-up recommended. Use safer alternative or discontinue breastfeeding from 5 to 7 T ½ . Read Commentary.

A non-steroidal synthetic estrogen similar to diethylstilbestrol.

Since the last update we have not found published data about its excretion in breast milk.

It has been used orally to inhibit postpartum lactation (Oladapo 2012, Niebyl 1979, Yuen 1977, Utian 1975) and to treat menopausal symptoms, female hypogonadism and prostate carcinoma.

Very long acting due to accumulation in adipose tissue.

Not currently commercially available.


See below the information of this related product:

  • Diethylstilbestrol (Very unsafe. Contraindicated. Use of an alternative or cessation of breastfeeding. Read the Commentary.)

Alternatives

We do not have alternatives for كلوروتريانيزان.

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.
DONATE NOW

Other names

كلوروتريانيزان is Chlorotrianisene in Arabic.

Is written in other languages:

كلوروتريانيزان is also known as

Group

كلوروتريانيزان belongs to this group or family:

Tradenames

Main tradenames from several countries containing كلوروتريانيزان in its composition:

Pharmacokinetics

Variable Value Unit
Molecular weight 381 daltons
Protein Binding 50 - 80 %

References

  1. Oladapo OT, Fawole B. Treatments for suppression of lactation. Cochrane Database Syst Rev. 2012 Abstract
  2. Niebyl JR, Bell WR, Schaaf ME, Blake DA, Dubin NH, King TM. The effect of chlorotrianisene as postpartum lactation suppression on blood coagulation factors. Am J Obstet Gynecol. 1979 Abstract
  3. Yuen BH, Pendleton HJ, Blair S. Efficacy of bromocriptine and chlorotrianisene in preventing postpartum lactation. Can Med Assoc J. 1977 Abstract
  4. Utian WH, Begg G, Vinik AI, Paul M, Shuman L. Effect of bromocriptine and chlorotrianisene on inhibition of lactation and serum prolactin. A comparative double-blind study. Br J Obstet Gynaecol. 1975 Abstract

Total visits

1,922

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by La Liga de la Leche de México of Mexico

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM